Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Legality  




2 See also  




3 References  













4-Methyl-α-ethyltryptamine






●Српски / srpski
 ●Srpskohrvatski / српскохрватски
 ●中文
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  
(Redirected from 4-Methyl-AET)
4-Methyl-α-ethyltryptamine
Clinical data
ATC code
  • none
Legal status
Legal status
  • Illegal in Singapore
Identifiers

  • 1-(4-Methyl-1H-indol-3-yl)butan-2-amine

CAS Number
PubChem CID
ChemSpider
UNII
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC13H18N2
Molar mass202.301 g·mol−1
3D model (JSmol)

  • Cc2c1c(CC(N)CC)c[nH]c1ccc2

  • InChI=1S/C13H18N2/c1-3-11(14)7-10-8-15-12-6-4-5-9(2)13(10)12/h4-6,8,11,15H,3,7,14H2,1-2H3 checkY

  • Key:XKHCIOVNXOVPIK-UHFFFAOYSA-N checkY

  (verify)

4-Methyl-α-ethyltryptamine (4-Me-αET) is a putative stimulant, psychedelic, and entactogen drug of the tryptamine class.[1] It is a designer drug and is sold online as a "research chemical".[2]

Legality[edit]

4-Methyl-α-ethyltryptamine is illegal in Singapore.[3]

See also[edit]

References[edit]

  1. ^ Cerletti A, Taeschler M, Weidmann H (1968). "Pharmacologic studies on the structure-activity relationship of hydroxyindole alkylamines". Pharmacology, Behavior, and Clinical Aspects, Proceedings of a Symposium held at the College of Physicians and Surgeons, Columbia University, New York. Advances in Pharmacology. Vol. 6. pp. 233–46. doi:10.1016/s1054-3589(08)60322-1. ISBN 978-0-12-032906-9. PMID 5658327.
  • ^ Chapman SJ (1 Mar 2018). "PeakAL: Protons I Have Known and Loved, Too — Another Fifty Shades of Grey-Market Spectra". Blotter (5). doi:10.16889/isomerdesign-5. Retrieved 3 April 2018.
  • ^ "Misuse of Drugs Act - Singapore Statutes Online". sso.agc.gov.sg.


    • Stub icon

    This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=4-Methyl-α-ethyltryptamine&oldid=1211185508"
    Categories: 
    ●Drugs not assigned an ATC code
     ●Psychedelic tryptamines
     ●Serotonin receptor agonists
     ●Serotonin-norepinephrine-dopamine releasing agents
     ●Entactogens and empathogens
     ●Nervous system drug stubs
     Hidden categories: 
    ●Articles with short description
     ●Short description matches Wikidata
     ●Drugs with non-standard legal status
     ●Articles without EBI source
     ●Chemical pages without DrugBank identifier
     ●Articles without KEGG source
     ●All stub articles
      


    ●This page was last edited on 1 March 2024, at 07:38 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki